Log in

Relevant bibliographies by topics / HIV/Hepatitis C / Journal articles

To see the other types of publications on this topic, follow the link: HIV/Hepatitis C.

Journal articles on the topic 'HIV/Hepatitis C'

Author: Grafiati

Published: 31 August 2024

Last updated: 19 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'HIV/Hepatitis C.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Crobu, Maria Grazia, Paolo Ravanini, Clotilde Impaloni, et al. "Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection." Viruses 16, no. 6 (2024): 992. http://dx.doi.org/10.3390/v16060992.

Full text

Abstract:

Previous studies reported that the hepatitis C virus (HCV) could help disseminate the hepatitis D virus (HDV) in vivo through the unrelated hepatitis B virus (HBV), but with essentially inconclusive results. To try to shed light on this still-debated topic, 146 anti-HCV-positive subjects (of whom 91 HCV/HIV co-infected, and 43 with prior HCV eradication) were screened for anti-HDV antibodies (anti-HD), after careful selection for negativity to any serologic or virologic marker of current or past HBV infection. One single HCV/HIV co-infected patient (0.7%) tested highly positive for anti-HD, bu

APA, Harvard, Vancouver, ISO, and other styles

2

Qadeer, Muhammad Imran, Muhammad Aslamkhan, Muhammad Shoaib Akhtar, and Fazal Ellahi. "High Seropositivity of HIV, Hepatitis and Syphilis in Prisoner Blood Donors than the General Population Volunteers from the Punjab, Pakistan –A Longitudinal 13 Years Study." International Journal of Frontier Sciences 1, no. 1 (2019): 2–11. https://doi.org/10.5281/zenodo.2545868.

Full text

Abstract:

Abstract: Background: HBV, HCV, HIV and Syphilis are leading transfusion transmitted infections. Blood donors are screened against these infectious diseases before transfusion to patients. Methods: Data of general population and volunteer prisoner blood donors is retrieved from records of January 2007 to September 2009. Data is analysed using Epi Info version 3.5.1. Blood donors were screened using ELISA method against HCV, HBV, and HIV while VDRL method is used for screening against Syphilis. Results: Prevalence of HBV, HCV, HIV, and Syphilis in general population blood donors is 3.3%, 4.7%,

APA, Harvard, Vancouver, ISO, and other styles

3

Shrestha, Lok Bahadur, Gopal K. Yadav, Saugat Pradhan, et al. "Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal." PLOS ONE 17, no. 3 (2022): e0264791. http://dx.doi.org/10.1371/journal.pone.0264791.

Full text

Abstract:

Introduction This study was conducted with an objective to analyze prevalence and risk factors associated with co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-positive patients with reference to their CD4+ T cell status. Materials and methods HIV-positive patients visiting the HIV clinic for CD4+ T cells testing at B.P. Koirala Institute of Health Sciences were tested for Hepatitis B and Hepatitis C. Data regarding age, gender, mode of HIV transmission, duration of HIV diagnosis, antiretroviral therapy status, antiretroviral therapy duration, hepatitis B or C status,

APA, Harvard, Vancouver, ISO, and other styles

4

Zezerti, Idriss Mamadou, Abdelsalam Adoum Doutoum, Alhadj Markhous Nazal, et al. "Seroprevalence of HIV with Hepatitis B and C Co-Infection in Patients at the Al Nadjma Multi-purpose Center Laboratory in N'Djamena, Chad." Microbiology Research Journal International 35, no. 2 (2025): 54–62. https://doi.org/10.9734/mrji/2025/v35i21542.

Full text

Abstract:

Co-infection with hepatitis B and C is one of the major challenges in the management of HIV since access to antiretroviral drugs has improved in Africa. The aim of this study was to determine the seroprevalence HIV/Hep B and C co-infection in patients treated at the Al Nadjma multi-purpose centre in N'Djamena, Chad. This prospective study was conducted from June 2023 to May 2024 on 3,430 patients seen at the laboratory of the Al Nadjma multi-purpose Center in N'Djamena for screening for both HIV and hepatitis B and C. HIV was detected by immuno-chromatography using specific kits. The detection

APA, Harvard, Vancouver, ISO, and other styles

5

Dickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann, and Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection." European Addiction Research 22, no. 4 (2015): 181–91. http://dx.doi.org/10.1159/000441973.

Full text

Abstract:

Background/Aims: We report on the rates of hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in 1,313 clients entering heroin-assisted treatment (HAT) in Switzerland from 2003 to 2013. We identify predictors of HCV infection. Methods: Data were collected using questionnaires within 2 weeks of clients' first entry into HAT. Prevalence of HAV, HBV, HCV and HIV was calculated using laboratory test results collected at entry or using reports of older test results. Predictors of HCV status were identified through multiple logistic regre

APA, Harvard, Vancouver, ISO, and other styles

6

Sattarova, Gulsunai. "PREVALENCE AND GENOTYPES OF HEPATITIS B AND C VIRUS AMONG HIV-INFECTED PEOPLE." Alatoo Academic Studies 23, no. 3 (2023): 497–506. http://dx.doi.org/10.17015/aas.2023.233.50.

Full text

Abstract:

Viruses of parenteral hepatitis HBV, HCV and human immunodeficiency (HIV) are characterized by similar transmission routes and risk groups, in which the probability of acquiring two or more of these infections at once is increased. The aim of the research is to study the prevalence and determine the genotypes of hepatitis B and C virus circulating among HIV-infected people. The results of the studies show a high prevalence of HCV markers (HCV – 45% and HBV- 16%) among HIV-infected people. Co-infected patients had high viral replication of HBV (60%) and HCV (62.7%). Аlso by molecular genetic me

APA, Harvard, Vancouver, ISO, and other styles

7

Tserashkou, D. V., V. M. Mitsura, E. V. Voropaev, and O. V. Osipkina. "VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE." Hepatology and Gastroenterology 4, no. 2 (2020): 171–76. http://dx.doi.org/10.25298/2616-5546-2020-4-2-171-176.

Full text

Abstract:

Background. Hepatitis B virus (HBV) infection remains a global public health problem. Objective – to analyze the prevalence of viral coinfections with human immunodefciency virus (HIV), hepatitis C virus (HCV), hepatitis delta virus (HDV), TT-viruses and SENV in patients with chronic hepatitis B (CHB) and to assess their inﬂuence on liver disease severity. Material and methods. The observational cross-sectional study included 287 patients with chronic hepatitis B virus (HBV) – those with monoinfection and coinfected with HIV, HCV, HDV. Routine hematological and biochemical tests were performed

APA, Harvard, Vancouver, ISO, and other styles

8

Mr., Keshava Reddy M., and Senthil Thirusangu Mr. "Viral Hepatitis - Disease Burden, Challenges and Gap Analysis with Existing Response." International Journal of Trend in Scientific Research and Development 3, no. 3 (2019): 545–47. https://doi.org/10.31142/ijtsrd22823.

Full text

Abstract:

Viral hepatitis is a global public health problem of epidemic proportions that caused 1.34 million deaths in 2015 a number comparable to deaths caused by tuberculosis and higher than those caused by HIV. Infection can be caused by the five known hepatitis viruses - A, B, C, D and E HAV, HBV, HCV, HDV and HEV . Many of these infections are preventable. Hepatitis B and C are responsible for 96 of overall hepatitis mortality. In India, the estimated burden of hepatitis is very high, necessitating focus on prevention and control measures to mitigate morbidity and mortality arising out of hepatitis

APA, Harvard, Vancouver, ISO, and other styles

9

Seyoum, Eleni, Meaza Demissie, Alemayehu Worku, Andargachew Mulu, Alemseged Abdissa, and Yemane Berhane. "HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study." PLOS ONE 17, no. 4 (2022): e0267230. http://dx.doi.org/10.1371/journal.pone.0267230.

Full text

Abstract:

Introduction HIV co-infection with hepatitis B (HIV-HBV) and hepatitis C (HIV-HCV) is known to affect treatment outcomes of antiretroviral therapy (ART); however, its magnitude is not well documented. We aimed to determine the magnitude of HIV-HBV and HIV-HCV co-infections simultaneously in people living with HIV (PLHIV) enrolled in ART care in Addis Ababa. Methods We reviewed the medical records of adults ≥15 years who were receiving ART care in three high burden hospitals in Addis Ababa. Baseline clinical and laboratory test results were extracted from medical records. Co-infection was deter

APA, Harvard, Vancouver, ISO, and other styles

10

Suman, Sonu. "Clinical, haematological, and biochemical profile of HIV patient co-infected with hepatitis B and /or C." International Journal of Research in Medical Sciences 8, no. 11 (2020): 3955. http://dx.doi.org/10.18203/2320-6012.ijrms20204885.

Full text

Abstract:

Background: Human immunodeficiency virus (HIV) positive population is at higher risk of getting infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) or both. Co-infection with HBV/HCV may possibly complicate the clinical course of HIV in infected patients. Aim and objectives of the study were intended to determine clinical, haematological and biochemical profile of HIV patients co infected with hepatitis B and/or C.Methods: All consecutive patients presented with HIV infection who were coinfected with either Hepatitis B, C or both presenting to immunodeficiency or Gastroenterology

APA, Harvard, Vancouver, ISO, and other styles

11

Riddhi Pradhan, Kirti Hemwani, Vidit Khandelwal, Bamboriya BL, Yogyata Marothi, and Varsha Saxena. "A cross-sectional study on co-infection of hepatitis B and hepatitis C among people living with HIV/AIDS from a tertiary care hospital of Central India." Asian Journal of Medical Sciences 14, no. 4 (2023): 61–67. http://dx.doi.org/10.3126/ajms.v14i4.50299.

Full text

Abstract:

Background: Hepatitis B virus (HBV), hepatitis C virus (HCV), and Human immunodeficiency virus (HIV) infections are prevalent throughout the world. HIV infection increases the risk of HBV and HCV liver disease especially when HIV-associated immunodeficiency progresses. Aims and Objectives: This study was carried out with the objectives as follows: Estimation of the prevalence of HIV- Hepatitis co-infection, determine CD4+T lymphocyte count in co-infected patients, identify most common opportunistic infections in HIV – Hepatitis co- infection. Materials and Methods: A hospital-based, prospectiv

APA, Harvard, Vancouver, ISO, and other styles

12

Basimane-Bisimwa, Parvine, Giscard Wilfried Koyaweda, Edgarthe Ngaïganam, et al. "Seroprevalence and molecular characterization of viral hepatitis and HIV co-infection in the Central African Republic." PLOS ONE 19, no. 5 (2024): e0291155. http://dx.doi.org/10.1371/journal.pone.0291155.

Full text

Abstract:

Background The Central African Republic (CAR) is one of the countries with the highest prevalence of viral hepatitis infection in the world. Coinfection with HIV increases the morbidity and mortality beyond that of mono-infection with either hepatitis or HIV. The present study describes the geographic distribution of viral hepatitis infections and molecular characterization of these viruses in the CAR. Methodology Out of 12,599 persons enrolled during the fourth Multiple Indicator Cluster Survey of 2010 in the CAR, 10,621 Dried Blood Spot (DBS) samples were obtained and stored at -20°C. Of the

APA, Harvard, Vancouver, ISO, and other styles

13

Guo, Fuying, and Lingzhou Yang. "Research Progress on HIV/AIDS with Concomitant Hepatitis B Virus and/or Hepatitis C Virus Infection." Infection International 4, no. 1 (2015): 16–20. http://dx.doi.org/10.1515/ii-2017-0099.

Full text

Abstract:

Abstract Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) involve similar transmission routes, namely, blood, sexual contact, and mother-baby contact. Therefore, HIV infection is usually accompanied by HBV and HCV infections. This observation poses a great challenge to the prevention and treatment of HIV/human acquired immunodeficiency syndrome (AIDS) accompanied by HBV and HCV infection. Highly active antiretroviral therapy (HAART) has been extensively applied. Hence, liverrelated diseases have become the main causes of complication and death in HIV-inf

APA, Harvard, Vancouver, ISO, and other styles

14

Ullah, Qudrat, Usman Ali Rehman, Asif Hanif, and Sami Ullah Bhatti. "Frequency of Parenteral Exposure and Seroprevalence of HBV, HCV and HIV among Operating Room Personnel." International Journal of Frontier Sciences 2, no. 2 (2018): 3–10. https://doi.org/10.5281/zenodo.2545981.

Full text

Abstract:

Abstract Background: There are many experiences in the operation theatre professionals to get Hepatitis B virus, Hepatitis C virus and Human immunodeficiency virus during their profession in operating room due to accidental needle pricks or through cut by any sharp. The objective of this study is to find out the Frequency of parenteral exposure and seroprevalence of HBV, HCV and HIV among operating room personnel. Methodology: Frequency of parenteral exposure and seroprevalence of HBV, HCV and HIV among operating room personnel was found using ICT method. Results: All 108 (100 %) operating roo

APA, Harvard, Vancouver, ISO, and other styles

15

Ramezani, A., M. Mohraz, A. Aghakhani, et al. "Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals." International Journal of STD & AIDS 20, no. 5 (2009): 336–38. http://dx.doi.org/10.1258/ijsa.2008.008377.

Full text

Abstract:

Association between isolated hepatitis B core antibody (anti-HBc) and hepatitis C virus (HCV) infection has been noted in HIV-infected individuals. This study describes the frequency of isolated anti-HBc and its possible value for the detection of HBV-DNA in HIV-infected patients with or without HCV co-infection. Ninety-two HIV-infected patients were enrolled in the study. Hepatitis B surface antigen (HBs Ag), anti-HBs, anti-HBc, anti-HCV, HIV viral load and CD4 count were tested in all subjects. Then we compared 63 subjects with HIV-HCV co-infection with 29 subjects with HIV infection alone r

APA, Harvard, Vancouver, ISO, and other styles

16

Zaki, Amal, Maria Sabir, and Fatima El Omari. "HEPATITIS B, HEPATITIS C AND HIV AMONG DRUG USERS IN METHADONE MAINTENANCE TREATMENT: PREVALENCE, DOSES, TREATMENT COMPLIANCE." International Journal of Advanced Research 11, no. 02 (2023): 763–69. http://dx.doi.org/10.21474/ijar01/16308.

Full text

Abstract:

TheUsersofopioidsubstances,especiallyinjectingdrugs,areathighriskofinfection with blood- borne viruses,such as hepatitis B,C and human immunodeficiency virus, due to the sharing of needles and injection equipment. Methadone substitution treatment is approven device in the risk reduction strategy of hepatitis B,C and HIV infection.The aim of this studyis to determine: the socio-demographic and medical psychiatric characteristics of patients with hepatitis B,C and HIV under methadone,the prevalence of hepatitis C,B and HIV,the dose of methadone and compliance with treatment in this population. M

APA, Harvard, Vancouver, ISO, and other styles

17

Brook, M. G., K. Jones, A. W. S. Dale, and R. F. Miller. "Management of HIV and hepatitis B or C co-infection in 15 HIV treatment centres. Disparity between protocols and practice." International Journal of STD & AIDS 14, no. 7 (2003): 469–72. http://dx.doi.org/10.1258/095646203322025777.

Full text

Abstract:

Our aim was to ascertain current guidelines and clinical practices prevalent in HIV treatment centres in the North Thames Region of England on the care of patients co-infected with HIV and hepatitis B or C. A self-completed postal survey of clinic guidelines and retrospective case-note reviews was performed. Fifteen of the 27 units completed the survey and generally had clinic guidelines consistent with current national guidelines. Stated policy was usually to screen HIV patients for hepatitis B virus (HBV) and hepatitis C virus (HCV) and to offer specific therapy for the hepatitis as well as

APA, Harvard, Vancouver, ISO, and other styles

18

Alexiev, Ivailo, Elitsa Golkocheva-Markova, Asya Kostadinova, et al. "The prevalence of hepatitis B and C co-infections among people with HIV-1 in Bulgaria: 2010–2015." Future Virology 14, no. 12 (2019): 791–98. http://dx.doi.org/10.2217/fvl-2019-0092.

Full text

Abstract:

Aim: To evaluate hepatitis B virus (HBV) and hepatitis C virus (HCV) among individuals with HIV/AIDS in Bulgaria diagnosed between 2010 and 2015. Materials & methods: A total of 1158 individuals were diagnosed with HIV/AIDS during the study period. Different transmission groups were tested with ELISA and real-time PCR for HBV and HCV markers. Results: Hepatitis B surface antigen and hepatitis C virus antiboby were found in 9.3 and 23.2% of the tested. HBV DNA and HCV RNA has been found in 47.4 and 69.6%. Hepatitis B and C co-infections were predominant in multiple risk behavior groups, inc

APA, Harvard, Vancouver, ISO, and other styles

19

TÁVORA, Lara Gurgel Fernandes, Elodie Bomfim HYPPOLITO, José Napoleão Monte da CRUZ, Nyvia Maria Barroso PORTELA, Samuel Montenegro PEREIRA, and Camila Monteiro VERAS. "HEPATITIS B, C AND HIV CO-INFECTIONS SEROPREVALENCE IN A NORTHEAST BRAZILIAN CENTER." Arquivos de Gastroenterologia 50, no. 4 (2013): 277–80. http://dx.doi.org/10.1590/s0004-28032013000400007.

Full text

Abstract:

ContextThe occurrence of HIV and hepatitis B (HBV) and C (HCV) virus associations is of great concern since co-infected patients respond poorly to antiviral treatment and usually progress to chronic and more complicated hepatic disease. In Brazil, these co-infections prevalence is not well known since published data are few and sometimes demonstrate conflicting results. Also, a significant number of co-infected individuals are HBV/HCV asymptomatic carriers, leading to under notification.ObjectivesThe present study aimed to determine the prevalence of the HBV and HCV infection in a recently dia

APA, Harvard, Vancouver, ISO, and other styles

20

FAYYAZ, MOHAMMAD, Muhammad Ayub Khan, MASROOR ALI QAZI, Ghulam Mohyud Din `Chaudhary, and GULZAR AHMED. "HEPATITIS B, C & HIV." Professional Medical Journal 13, no. 04 (2006): 632–36. http://dx.doi.org/10.29309/tpmj/2006.13.04.4941.

Full text

Abstract:

Objective: To determine the prevalence of HBV, HCV and HIV in healthyblood donors in Blood Transfusion Services, Bahawal Victoria Hospital, Bahawalpur. Design: Prospective observationalstudy. Setting: Blood Transfusion Services, Bahawal Victoria Hospital (BVH), affiliated with Quaid-e-Azam medicalCollege Bahawalpur. Period: From 1 January t st o 31st December 2005. Methods and Materials: All the personscoming for blood donations , at the BVH facility, were included. Clinically anaemic, ill, past history of jaundice and ageof less than 18 or more than 50 years were excluded. All the donors (279

APA, Harvard, Vancouver, ISO, and other styles

21

Kartashov, Mikhail Yu, Kirill A. Svirin, Ekaterina I. Krivosheina, Elena V. Chub, Vladimir A. Ternovoi, and Galina V. Kochneva. "Prevalence and molecular genetic characteristics of parenteral hepatitis B, C and D viruses in HIV positive persons in the Novosibirsk region." Problems of Virology 67, no. 5 (2022): 423–38. http://dx.doi.org/10.36233/0507-4088-133.

Full text

Abstract:

Introduction. Parenteral viral hepatitis (B, C, D) and HIV share modes of transmission and risk groups, in which the probability of infection with two or more of these viruses simultaneously is increased. Mutual worsening of the course of viral infections is important issue that occurs when HIV positive patients are coinfected with parenteral viral hepatitis. The aim of the study was to determine the prevalence of HCV, HBV and HDV in HIV positive patients in the Novosibirsk region and to give molecular genetic characteristics of their isolates. Materials and methods. Total 185 bloo

APA, Harvard, Vancouver, ISO, and other styles

22

Choy, Chiaw Yee, Li Wei Ang, Oon Tek Ng, Yee Sin Leo, and Chen Seong Wong. "Factors Associated with Hepatitis B and C Co-Infection among HIV-Infected Patients in Singapore, 2006–2017." Tropical Medicine and Infectious Disease 4, no. 2 (2019): 87. http://dx.doi.org/10.3390/tropicalmed4020087.

Full text

Abstract:

Co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) with human immunodeficiency virus (HIV) is associated with increased risk of hepatic complications and mortality. A retrospective study to estimate the proportion of HBV and HCV co-infections in Singapore was conducted using a clinical database. We included 3065 patients who were seen under the Clinical HIV Programme at the largest referral centre for HIV care between 2006 and 2017 and were tested for both HBV and HCV. Factors associated with HIV-HBV and HIV-HCV co-infections were determined using logistic regressions. The maj

APA, Harvard, Vancouver, ISO, and other styles

23

Tekin, Suda, Gule Cınar, Orcun Barkay, and Ilhami Celik. "HBV and HCV Coinfection in Patients Living with HIV." Klimik Dergisi/Klimik Journal 36, no. 1 (2023): 3–9. http://dx.doi.org/10.36519/kd.2023.4473.

Full text

Abstract:

Coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in human immunodeficiency virus (HIV) infected individuals results in increased hepatic complications. HBV and HIV viruses are transmitted by blood and unprotected sexual intercourse. People with HIV and HBV coinfection are at increased risk for liver-related morbidity and mortality. HCV-related liver injury progresses more rapidly among people coinfected with HIV. HCV coinfection may also affect the management of HIV infection. This review aims to go over the management of HIV-HCV and HIV-HBV coinfections.

APA, Harvard, Vancouver, ISO, and other styles

24

YAN, Y. X., Y. Q. GAO, X. SUN, et al. "Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients." Epidemiology and Infection 139, no. 3 (2010): 354–60. http://dx.doi.org/10.1017/s0950268810001597.

Full text

Abstract:

SUMMARYTo evaluate the prevalence of hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infections in HIV-infected patients in China, an epidemiological serosurvey was conducted from May 2007 to September 2008 using a random cluster sampling design of infectious disease hospitals in seven high HIV-prevalent provinces (municipalities). Univariate analysis and logistic regression were used to study the determinants of HIV and HBV and/or HCV co-infection. The overall prevalence was 41·83% (95% CI 40·36–43·30) for anti-HCV and 12·49% (95% CI 11·50–13·48) for HBsAg, respectively. The prevalence

APA, Harvard, Vancouver, ISO, and other styles

25

Shrestha, Umid Kumar, and Bhup Dev Bhatta. "Seroprevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in the western region of Nepal." Journal of Advances in Internal Medicine 5, no. 1 (2017): 6–10. http://dx.doi.org/10.3126/jaim.v5i1.17064.

Full text

Abstract:

Background and aims: The hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are associated with major public health concerns. The aim of the study was to determine the seroprevalence of HBV, HCV and HIV in the western region of Nepal.Methods: This was a cross-sectional observational study, in which 15,791 patients, attending to Manipal Teaching Hospital, Pokhara, Nepal, were investigated for HBV, HCV and HIV from June 2013 to March 2016; demographic and biochemical profile were studied among the patients with positive test results.Results: Among 15,791 pati

APA, Harvard, Vancouver, ISO, and other styles

26

Luma, Henry Namme, Servais Albert Fiacre Bagnaka Eloumou, Domin Sone Majunda Ekaney, et al. "Sero-prevalence and Correlates of Hepatitis B and C Co-infection Among HIV-infected Individuals in Two Regional Hospitals in Cameroon." Open AIDS Journal 10, no. 1 (2016): 199–208. http://dx.doi.org/10.2174/1874613601610010199.

Full text

Abstract:

Background:Liver disease related to Hepatitis B (HBV) and C (HCV) infection has become a major cause of morbidity and mortality in HIV/AIDS patients. Data on the prevalence of HBV and HCV in Cameroon remains inconclusive.Objective:We aimed to determine the sero-prevalence and correlates of Hepatitis markers in HIV/AIDS patients in two Regional Hospitals.Methods:A cross-sectional study carried out from December 2014 to March 2015. HIV/AIDS patients aged 21 were included and above, receiving care at HIV treatment centres. Data was collected using a structured questionnaire. Blood samples were co

APA, Harvard, Vancouver, ISO, and other styles

27

Zhang, Chao, Qiang Ren, and Wenhui Chang. "Epidemiological Features and Risk Factors for Acquiring Hepatitis B, Hepatitis C, and Syphilis in HIV-Infected Patients in Shaanxi Province, Northwest China." International Journal of Environmental Research and Public Health 17, no. 6 (2020): 1990. http://dx.doi.org/10.3390/ijerph17061990.

Full text

Abstract:

Human immunodeficiency virus (HIV)-infected patients are at a higher risk for co-infection with Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Treponema pallidum (TP; the agent causing syphilis) than the general population. The prevalence of HBV, HCV, and syphilis has geographic differences and varies from region to region among HIV-positive individuals. A retrospective study was carried out on HIV-positive individuals between June 2011 and June 2016 in Shaanxi Province. Univariate and multivariate logistic regression analyses using stepwise regression analysis regarding risk factors fo

APA, Harvard, Vancouver, ISO, and other styles

28

Pathare, Anil, and Salam Alkindi. "PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN." Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (2019): e2019058. http://dx.doi.org/10.4084/mjhid.2019.058.

Full text

Abstract:

Background: In Oman, the prevalence of hepatitis B (HBV) infection is 5.8% with 2.8–7.1% HBV carriers. Hepatitis C (HCV) prevalence amongst Omanis is 0.41%. A total of 2917 human immunodeficiency virus (HIV) infections were notified amongst Omanis by 2017. This study was performed as there was no data on the prevalence of HIV, HBV and HCV in sickle cell disease (SCD) patients from Oman.  Study Design and Methods: In this retrospective, cross-sectional study, medical records of all SCD patients who attended our hospital between 2011 to 2017 were retrieved from the hospital informati

APA, Harvard, Vancouver, ISO, and other styles

29

Troisi, CL, FB Hollinger, WK Hoots, et al. "A multicenter study of viral hepatitis in a United States hemophilic population." Blood 81, no. 2 (1993): 412–18. http://dx.doi.org/10.1182/blood.v81.2.412.412.

Full text

Abstract:

Abstract Hemophilia A and B patients seen at nine US regional treatment centers were tested for serologic markers of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) during 1987 and 1988. Because human immunodeficiency virus (HIV) infection, a potentially confounding variable, was present in 53% of the group, the population was divided by HIV status for analysis purposes. In the HIV-positive group (N = 382), less than 1% had not been infected with HBV, HCV, or HDV, whereas 75% had evidence of infection with HBV and 98% with HCV. HBsAg, a marker of active HBV in

APA, Harvard, Vancouver, ISO, and other styles

30

Troisi, CL, FB Hollinger, WK Hoots, et al. "A multicenter study of viral hepatitis in a United States hemophilic population." Blood 81, no. 2 (1993): 412–18. http://dx.doi.org/10.1182/blood.v81.2.412.bloodjournal812412.

Full text

Abstract:

Hemophilia A and B patients seen at nine US regional treatment centers were tested for serologic markers of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) during 1987 and 1988. Because human immunodeficiency virus (HIV) infection, a potentially confounding variable, was present in 53% of the group, the population was divided by HIV status for analysis purposes. In the HIV-positive group (N = 382), less than 1% had not been infected with HBV, HCV, or HDV, whereas 75% had evidence of infection with HBV and 98% with HCV. HBsAg, a marker of active HBV infection,

APA, Harvard, Vancouver, ISO, and other styles

31

Dorothy Nnakenyi, Ifeyinwa, Chisom Uchechukwu, and Uloaku Nto-ezimah. "Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria." African Health Sciences 20, no. 2 (2020): 579–86. http://dx.doi.org/10.4314/ahs.v20i2.5.

Full text

Abstract:

Background: The health of people living with HIV/AIDS becomes progressively worse when co-infected with hepatitis B virus (HBV) and hepatitis C virus (HCV), resulting in shortened life span. The modes of transmission of HIV, HBV and HCV are similar. Objective: To determine the prevalence of HBV and HCV co-infection in HIV patients. Method: This was a retrospective study of serology test results for hepatitis B surface antigen (HBsAg) and antibodies to HCV (anti-HCV) of HIV positive patients registered from 2008-2013 (6years) at the University of Nigeria Teaching Hospi- tal. Adult p

APA, Harvard, Vancouver, ISO, and other styles

32

BUREK, V., J. HORVAT, K. BUTORAC, and R. MIKULIĆ. "Viral hepatitis B, C and HIV infection in Croatian prisons." Epidemiology and Infection 138, no. 11 (2010): 1610–20. http://dx.doi.org/10.1017/s0950268810000476.

Full text

Abstract:

SUMMARYIncarcerated persons comprise about 0·4% of the Croatian population, of whom 25–30% misuse drugs. We attempted to determine the structure of the prison population, prevalence of HBV, HCV, HIV markers, co-infections with HBV, HCV and HIV and acute HBV, HCV and HIV infection. In total, 25·9% of prisoners were positive for some markers for viral hepatitis (HBV 11·3%, HCV 8·3%, HBV/HCV 6·3%). Prevalence of HBV infection in intravenous drug users (IDUs) was 26·2% (highly promiscuous group 20·4%, individuals with psychiatric diseases and personality disorders 16·0%). HCV infection in IDUs was

APA, Harvard, Vancouver, ISO, and other styles

33

Kurniawati, Sri Agustini, Teguh H. Karjadi, and Rino A. Gani. "Faktor - Faktor yang Berhubungan dengan Kejadian Hepatitis C pada Pasangan Seksual Pasien Koinfeksi Human Immunodeficiency Virus dan Virus Hepatitis C." Jurnal Penyakit Dalam Indonesia 2, no. 3 (2017): 133. http://dx.doi.org/10.7454/jpdi.v2i3.78.

Full text

Abstract:

Pendahuluan. Pencegahan transmisi hepatitis C pada pasangan seksual pasien koinfeksi HIV/HCV merupakan upaya penatalaksanaan hepatitis C. Namun demikian, belum ada data prevalensi hepatitis C dan faktor yang berhubungan dengan transmisi hepatitis C pada pasangan seksual pasien koinfeksi HIV/HCV di Indonesia, sehingga perlu dilakukan penelitian untuk memperoleh data tersebut. Penelitian ini bertujuan untuk mengetahui prevalensi hepatitis C dan faktor-faktor yang berhubungan dengan kejadian hepatitis C pada pasangan seksual pasien koinfeksi HIV/HCV.Metode. Studi potong lintang pada pasangan hete

APA, Harvard, Vancouver, ISO, and other styles

34

Brackmann, SA, A. Gerritzen, J. Oldenburg, HH Brackmann, and KE Schneweis. "Search for intrafamilial transmission of hepatitis C virus in hemophilia patients." Blood 81, no. 4 (1993): 1077–82. http://dx.doi.org/10.1182/blood.v81.4.1077.1077.

Full text

Abstract:

Abstract This study was performed to determine the risk of family members of anti-hepatitis C virus (HCV)-positive hemophilia patients (index patients) for infection with HCV compared with the risk of acquiring hepatitis B virus (HBV), human immunodeficiency virus (HIV), and hepatitis A virus (HAV) infection. All index patients (n = 141) were found to be positive by first and second generation anti-HCV enzyme immunoassays (EIAs). Among their household contacts (n = 228), 224 were negative and 1 positive by both assays. Three contacts gave positive results in first generation anti-HCV EIA and n

APA, Harvard, Vancouver, ISO, and other styles

35

Brackmann, SA, A. Gerritzen, J. Oldenburg, HH Brackmann, and KE Schneweis. "Search for intrafamilial transmission of hepatitis C virus in hemophilia patients." Blood 81, no. 4 (1993): 1077–82. http://dx.doi.org/10.1182/blood.v81.4.1077.bloodjournal8141077.

Full text

Abstract:

This study was performed to determine the risk of family members of anti-hepatitis C virus (HCV)-positive hemophilia patients (index patients) for infection with HCV compared with the risk of acquiring hepatitis B virus (HBV), human immunodeficiency virus (HIV), and hepatitis A virus (HAV) infection. All index patients (n = 141) were found to be positive by first and second generation anti-HCV enzyme immunoassays (EIAs). Among their household contacts (n = 228), 224 were negative and 1 positive by both assays. Three contacts gave positive results in first generation anti-HCV EIA and negative r

APA, Harvard, Vancouver, ISO, and other styles

36

Behl, Shreya, Aaditya Behl, Pratibha Mane, Jyoti Sangwan, and Prakriti Vohra. "Seroprevalence of Hepatitis B and C co-infection in HIV seropositive and HIV seronegative cases in a Tertiary care hospital in Southern Haryana." IP International Journal of Medical Microbiology and Tropical Diseases 9, no. 2 (2023): 98–104. http://dx.doi.org/10.18231/j.ijmmtd.2023.019.

Full text

Abstract:

HBV (Hepatitis B virus) and HCV (Hepatitis C virus) are the causative agents of acute as well as chronic hepatitis. Nearly, two billion people are suffering with HBV and approximately 170 million people are infected with HCV infection around the world. While patients who are infected with HIV (Human Immunodeficiency Virus) 2-4 million are found to be having chronic HBV co-infection and 4-5 million are having HCV coinfection. Due to common mode of transmission of HIV, HBV and HCV like using shared needles, syringes, other injectable devices, sexual intercourse, or even mother to baby transmissi

APA, Harvard, Vancouver, ISO, and other styles

37

Jordan, Ashly E., David C. Perlman, Joshua Neurer, Daniel J. Smith, Don C. Des Jarlais, and Holly Hagan. "Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis." International Journal of STD & AIDS 28, no. 2 (2016): 145–59. http://dx.doi.org/10.1177/0956462416630910.

Full text

Abstract:

Since 2000, an increase in hepatitis C virus infection among HIV-infected (HIV+) men who have sex with men has been observed. Evidence points to blood exposure during sex as the medium of hepatitis C virus transmission. Hepatitis C virus prevalence among HIV + MSM overall and in relation to injection drug use is poorly characterized. In this study, a systematic review and meta-analysis examining global hepatitis C virus antibody prevalence and estimating active hepatitis C virus prevalence among HIV + MSM were conducted; 42 reports provided anti-hepatitis C virus prevalence data among HIV + MS

APA, Harvard, Vancouver, ISO, and other styles

38

Makuza, Jean Damascene, Marie Paul Nisingizwe, Jean Olivier Twahirwa Rwema, et al. "Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study." BMJ Open 10, no. 7 (2020): e036711. http://dx.doi.org/10.1136/bmjopen-2019-036711.

Full text

Abstract:

ObjectivesThis study describes the burden of the hepatitis B, C and HIV co-infections and assesses associated risk factors.SettingThis analysis used data from a viral hepatitis screening campaign conducted in six districts in Rwanda from April to May 2019. Ten health centres per district were selected according to population size and distance.ParticipantsThe campaign collected information from 156 499 participants (51 496 males and 104 953 females) on sociodemographic, clinical and behavioural characteristics. People who were not Rwandan by nationality or under 15 years old were excluded.Prima

APA, Harvard, Vancouver, ISO, and other styles

39

Mehta, Krunal Dineshbhai, Sejul Antala, Madhulika Mistry, and Yogesh Goswami. "Seropositivity of hepatitis B, hepatitis C, syphilis, and HIV in antenatal women in India." Journal of Infection in Developing Countries 7, no. 11 (2013): 832–37. http://dx.doi.org/10.3855/jidc.2764.

Full text

Abstract:

Introduction: The epidemiology of viral hepatitis during pregnancy is of paramount importance for health planners and program managers. Data on viral hepatitis during pregnancy are not readily available. This study was conducted to assess the extent of seropositivity of hepatitis B, hepatitis C, HIV, and syphilis in pregnant women and to re-evaluate the need for routine antenatal care screening. Methodology: All samples were tested to detect HBsAg by enzyme linked immunosorbent assay (ELISA). Samples were tested to detect anti-HCV by ELISA. Samples were also tested for antibodies to Treponema

APA, Harvard, Vancouver, ISO, and other styles

40

B.T., Osuolale, Ayo-Dada O.D., and Fasuan O.S. "Assessing Knowledge, Attitudes, and Practices on HIV-Hepatitis Co-infection among Expectant Mothers in Ekiti South, Nigeria." Asian Journal of Research in Infectious Diseases 16, no. 6 (2025): 17–28. https://doi.org/10.9734/ajrid/2025/v16i6453.

Full text

Abstract:

Hepatitis B, hepatitis C, and HIV are blood-borne infections that pose a serious threat to human health, particularly in Nigeria and other sub-Saharan African countries. The infections continue to pose a serious threat to public health, particularly in areas like Ekiti State where they are endemic. Pregnant women's knowledge, attitudes, and practices regarding HBV, HCV, HIV infection, and mother-to-child transmission (MTCT) are poorly understood despite various control measures, the disease persists, necessitating a better understanding of pregnant women receiving prenatal care's knowledge, at

APA, Harvard, Vancouver, ISO, and other styles

41

Khamatova, A. A., A. I. Mazus, L. N. Mazankova, T. A. Chebotareva, and Yu F. Vlatskaya. "Prevalence of HIV/HCV co-infection in pregnant women. Risk factors for perinatal transmission of HIV/HCV." Infekcionnye bolezni 20, no. 1 (2022): 91–98. http://dx.doi.org/10.20953/1729-9225-2022-1-91-98.

Full text

Abstract:

The review provides up-to-date statistical data on the prevalence, transmission routes, and risks of perinatal transmission of hepatitis C virus, immunodeficiency virus, and variants of their co-infections from mother to child. The increase in the number of HIV/HCV co-infected women of reproductive age makes it urgent to develop a strategy for the prevention of vertical transmission of HIV/HCV co-infection based on the treatment of viral hepatitis C during pregnancy planning and three-stage prevention of perinatal transmission of HIV infection at the onset of pregnancy. Key words: HIV infectio

APA, Harvard, Vancouver, ISO, and other styles

42

Alkindi, Salam, Nada AL-Umairi, and Anil Pathare. "Prevalence of Hepatitis B, Hepatitis C and HIV in Sickle Cell Disease Patients from Oman." Blood 132, Supplement 1 (2018): 4916. http://dx.doi.org/10.1182/blood-2018-99-118435.

Full text

Abstract:

Abstract Background and Purpose: Oman is a country with an intermediate prevalence of Hepatitis B (HBV) carriers (2.8-7.1%, 20101), while the prevalence of HBV infection was 5.8% (20142). Hepatitis C (HCV) prevalence reported from Oman was 0.41% (20163). Further, a total of 2394 Human Immunodeficiency (HIV) infections were identified among Omanis (20134). Unfortunately, there are no studies on the prevalence of HIV, HBV and HCV in sickle cell disease (SCD) patients from Oman. Objectives: This study was therefore performed to estimate the prevalence of HBV, HCV and HIV among SCD patients from O

APA, Harvard, Vancouver, ISO, and other styles

43

Haradhan Kumar Mohajan. "Hepatitis G Viruses (HGV): A Study on Prevalence, Transmission, and Co-Infection." Innovation in Science and Technology 4, no. 5 (2025): 42–47. https://doi.org/10.63593/ist.2788-7030.2025.06.004.

Full text

Abstract:

Hepatitis virus infection is an increasing severe life-threating complication that gradually damages the liver. Hepatitis G is identified as a blood-borne pathogen that can cause various problems in human body. The hepatitis G virus (HGV) is also known as GB virus C (GBV-C) that is a newly described human virus of member of the Flaviviridae family and is similar genome organization as hepatitis C virus (HCV), and may be a cause of chronic liver disease. Some investigations have demanded that it is not associated with any known disease, but may be a cause of co-infection with HBV, HCV and HIV i

APA, Harvard, Vancouver, ISO, and other styles

44

Prasetyo, Afiono Agung, Paramasari Dirgahayu, Yulia Sari, Hudiyono Hudiyono, and Seiji Kageyama. "Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia." Journal of Infection in Developing Countries 7, no. 06 (2013): 453–67. http://dx.doi.org/10.3855/jidc.2965.

Full text

Abstract:

Introduction: This study was conducted to determine the current molecular prevalence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and human T lymphotropic virus-1/2 (HTLV-1/2) circulating among drug abuser inmates incarcerated in prisons located in Central Java, Indonesia. Methodology: Socio-epidemiological data and blood specimens were collected from 375 drug abuser inmates in four prisons. The blood samples were analyzed with serological and molecular testing for HIV, HBV, HCV, HDV, and HTLV-1/2. Results: The seroprevalence

APA, Harvard, Vancouver, ISO, and other styles

45

Talaie, Haleh, Atieh Mousavizadeh, and Behjat Barari. "The Low Prevalence of Hepatitis C Virus and Human Immunodeficiency Virus Coinfection and Hepatitis C Virus Mono-Infection Among Methadone Toxicity Patients." International Journal of Medical Toxicology and Forensic Medicine 10, no. 1 (2020): 28457. http://dx.doi.org/10.32598/ijmtfm.v10i1.28457.

Full text

Abstract:

the incidence of Hepatitis C Virus (HCV)and Human Immunodeficiency Virus(HIV) coinfection in People Who InjectDrugs (PWIDs) is a public health issue; itpresents various contentions to the healthcareproviders. Although antiretroviral therapy improvedthe life expectancy of HIV-infected people, HCV-relatedmortality turned into a greater concern among these individuals[1]. AccFurthermore, they mentioned, “injectingdrug users in the Taipei methadone maintenancetreatment program had a very high prevalence of HIV/HBV coinfection and HCV mono-infection”[2].Besides, a systematic review and meta-analysi

APA, Harvard, Vancouver, ISO, and other styles

46

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Full text

Abstract:

Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Depa

APA, Harvard, Vancouver, ISO, and other styles

47

Gurung, Kishor, T. P. Poudel, G. J. Shah, and D. Mishra. "Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus in Nepalgunj Medical College, Nepal." Journal of Nepalgunj Medical College 16, no. 1 (2018): 63–66. http://dx.doi.org/10.3126/jngmc.v16i1.24233.

Full text

Abstract:

Introduction: Human immune deficiency viruses (HIV), Hepatitis B viruses (HBV) and Hepatitis C viruses (HCV) are the three most common chronic viral pathogens known. The viruses have common routes of transmission (such as blood and blood products, sharing needles to inject drugs and sexual activities) and similar risk factors. Aim and objective: The aim of study was to determine the seroprevalence of HIV, HBV and HCV in Kohalpur Teaching Hospital, Nepalgunj Medical College. Materials and methods: This is a descriptive hospital based study. The study was conducted at Nepalgunj Medic

APA, Harvard, Vancouver, ISO, and other styles

48

Akıllı, Fatih Mehmet, Elif Nur Özbay Haliloğlu, Mehmet Mücahit Güncü, and Dilara Turan Gökçe. "Investigation of Hepatitis C, D, and HIV Seroprevalence and Evaluation of APRI and FIB-4 Scores in HbsAg-Positive Patients." Viruses 17, no. 4 (2025): 568. https://doi.org/10.3390/v17040568.

Full text

Abstract:

This study aimed to assess the prevalence of HDV (hepatitis delta virus), HCV (hepatitis C virus), and HIV (human immunodeficiency virus) coinfections among HBsAg-positive patients and to determine the severity of liver fibrosis and biochemical markers. Furthermore, the study sought to evaluate the noninvasive fibrosis scores (APRI and FIB4) in predicting the severity of liver disease in patients with hepatitis B. A retrospective analysis of 1434 patients with chronic HBV admitted between January 2020 and December 2024 was conducted at Sincan Tertiary Hospital. The positivity rates of the foll

APA, Harvard, Vancouver, ISO, and other styles

49

Dr., Iqra Fayyaz Dr. Atifa Anzar Dr. Maryam Jamil. "ANALYSIS OF TREATMENT OF HEPATITIS C VIRUS IN HIV/HCV CO-INFECTION." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 11 (2018): 12597–600. https://doi.org/10.5281/zenodo.1491764.

Full text

Abstract:

<strong><em>Introduction: </em></strong><em>Hepatitis C is an RNA flavivirus that infects 4 million people in the United States making up approximately 1.8% of the population, and 150-200 million worldwide. In persons with HIV, its prevalence is estimated to be approximately 50%. <strong>Aims and objectives: </strong>The basic aim of the study is to find the treatment of Hepatitis C Virus in HIV/HCV co-infection in Pakistan. <strong>Material and methods: </strong>This study was conducted at hospitals of Attock and Rawalpindi during Jan 2018 to July 2018. This study was done to find the treatme

APA, Harvard, Vancouver, ISO, and other styles

50

Pal, Sampa, Margaret C. Shuhart, Lisa Thomassen, et al. "Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo." Journal of Virology 80, no. 5 (2006): 2280–90. http://dx.doi.org/10.1128/jvi.80.5.2280-2290.2006.

Full text

Abstract:

ABSTRACT The role of viral factors in the pathogenesis of chronic hepatitis C is unknown. The objective of the present study was to characterize markers of hepatitis C virus (HCV) infection and replication in liver biopsy specimens obtained from 65 genotype 1-infected subjects, including 31 who were coinfected with human immunodeficiency virus (HIV), and to analyze associations between intrahepatic viral markers and hepatitis C disease severity. The percentages of liver cells harboring HCV genomes (%G) and replicative-intermediate RNAs (%RI) were evaluated using strand-specific in situ hybridi

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!